US5208228A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Aminomacrolides and derivatives having immunosuppressive activity
Assignee: Merck and Co Inc
•
Filing: 1991-05-13
•
Granted: 1993-05-04
•
Expires: 2011-05-13
Abstract
Abstract Aminomacrolides of the general structural Formula I: <IMAGE> have been prepared from suitable precursors by incorporation of a nitrogen substituent at C-3'' and/or C-4'' of the cyclohexyl ring. These macrolide immunosuppressants are useful in a mammalian host for the treatment of autoimmune diseases, infectious diseases and/or the prevention of rejection of foreign organ transplants. In addition, these macrolide immunosuppressants are useful in the topical treatment of inflammatory and hyperproliferative skin diseases and cutaneous manifestations of immunologically-mediated illnesses. Also, these macrolides are useful in the treatment of reversible obstructive airways disease, particularly asthma.
Inventors
- 👤 Hyun O. Ok
- 👤 Thomas R. Beattie
- 👤 Michael H. Fisher
- 👤 Matthew J. Wyvratt
- 👤 Mark Goulet
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 17:47
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/01
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
1384 words
A compound of formula I: ##STR16## or a pharmaceutically acceptable salt thereof, wherein: R is 1) methyl, 2) ethyl, 3) propyl, or 4) allyl; R 1 and R 2 are, independently, 1) --N 3 ; 2) --NHCN; 3) --NR 5 R 6 , wherein R 5 and R 6 are independently, a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are independently selected from the group consisting of: i) hydrogen, ii) --OH, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are independently, hydrogen, or C 1 -C 6 alkyl, unsubstituted or substituted with phenyl vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --S--C 1 -C 6 alkyl, x) --SO--C 1 -C 6 alkyl, xi) --SO 2 --C 1 -C 6 alkyl, xii) halo, xiii) --C 3 -C 7 -cycloalkyl, xiv) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are independently selected from the group consisting of: A) hydrogen, B) C 1 -C 6 alkyl, C) --OH, D) C 1 -C 6 alkoxy, E) --O--CO--C 1 -C 6 alkyl, F) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, G) --CONR 9 R 10 , H) --CO 2 H, I) --CO--O--C 1 -C 6 alkyl, J) halo, K) --NO 2 , L) --CN, and N) --CF 3 , xv) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, and xvi) --CF 3 , c) C 3 -C 12 alkenyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) C 3 -C 7 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, e) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, f) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, g) --SO 2 -phenyl, wherein phenyl is unsubstituted or substituted with with M, W and Y, wherein M, W and Y are as defined above, h) --SO 2 --C 1 -C 6 alkyl, i) or where R 5 and R 6 and the N to which they are attached may form an unsubstituted or substituted 3- to 7-membered heterocyclic ring which may include one or two additional heteroatoms independently selected from the group consisting of O, S, or NR 9 , wherein R 9 is as defined above, and where the substituent(s), attached to the carbon atom(s) in the heterocyclic ring is/are independently selected form the group consisting of: i) hydrogen, ii) --OH, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are independently, hydrogen, or C 1 -C 6 alkyl, unsubstituted or substituted with phenyl, vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --SH, x) halo, xi) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, xii) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, and xiii) --CF 3 ; 4) --N(R 5 )CO--O--R 11 , wherein R 5 is as defined above and R 11 is C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above; 5) --N(R 5 )CO--R 12 , wherein R 5 is as defined above and R 12 is a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, c) C 3 -C 12 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, e) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, or f) where R 5 and R 12 and the --NCO-- to which they are attached may form an unsubstituted or substituted 5- to 7-membered heterocyclic ring which may include one or two additional heteroatoms independently selected from the group consisting of O, S, or NR 9 , wherein R 9 is as defined above; 6) --N(R 13 )COCH(R 17 )NR 5 R 6 wherein R 5 and R 6 are as defined above, R 13 is selected from the definitions of R 5 , and R 17 is: a) hydrogen, b) C 1 -C 4 alkyl, unsubstituted or substituted with R 18 , wherein R 18 is selected from the group consisting of: i) --OH, ii) C 1 -C 6 alkoxy, iii) --O--CO--C 1 -C 6 alkyl, iv) --SH, v) --S--C 1 -C 6 alkyl, vi) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, vii) --CO 2 H, viii) --CONH 2 , ix) imidazolyl, x) indolyl, xi) phenyl, and xii) p-hydroxyphenyl, or c) phenyl; 7) --N(R 13 )CO(CH 2 ) m NR 5 R 6 , wherein m is 0 or 2-6, R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 , or where R 13 and R 5 and the --NCO(CH 2 ) m N-- to which they are attached may form an unsubstituted or substituted 5- to 7-membered heterocyclic ring; 8) --N═C(R 13 )--NR 5 R 6 , wherein R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 , and wherein if either R 5 or R 6 are hydrogen, the tautomeric structure --NHC(R 13 )═NR 5or6 is also possible; 9) --N(R 14 ) 3 + A - , wherein R 14 is C 1 -C 6 alkyl, unsubstituted or substituted with phenyl or naphthyl, and wherein A - is a counterion; 10) ##STR17## wherein R 15 and R 16 are independently, a) hydrogen, b) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, c) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, d) --CN, e) --CF 3 , f) --CO--C 1 -C 6 alkyl, or g) --CO--O--C 1 -C 6 alkyl; 11) hydroxy or C 1 -C 6 alkoxy, with the proviso that R 1 and R 2 are not simultaneously hydroxy, C 1 -C 6 alkoxy, or combinations thereof; or 12) where R 1 and R 2 may both be connected to form a 3- to 7-membered heterocyclic ring of the form: ##STR18## wherein p is zero or one, R 5 is as defined above, and Z is a) --CO--, b) --CS--, c) --CO--C 1 -alkyl, d) --CS--C 1 -alkyl, or e) C 1 -C 2 -alkyl, wherein the alkyl may be unsubstituted or substituted with one or more of the following: i) --OH, ii) C 1 -C 6 alkyl, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --S--C 1 -C 6 alkyl, x) --SO--C 1 -C 6 alkyl, xi) --SO 2 --C 1 -C 6 alkyl, xii) halo, xiii) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, or xiv) naphthyl unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above; R 3 is hydrogen, hydroxy, or C 1 -C 6 alkoxyl; R 4 is hydrogen, or R 3 and R 4 taken together form a double bond; X is 0 or (H,OH); and n is 1 or 2.
Claim 2
Dependent Claim
1384 words
A compound of formula I: ##STR16## or a pharmaceutically acceptable salt thereof, wherein: R is 1) methyl, 2) ethyl, 3) propyl, or 4) allyl; R 1 and R 2 are, independently, 1) --N 3 ; 2) --NHCN; 3) --NR 5 R 6 , wherein R 5 and R 6 are independently, a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are independently selected from the group consisting of: i) hydrogen, ii) --OH, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are independently, hydrogen, or C 1 -C 6 alkyl, unsubstituted or substituted with phenyl vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --S--C 1 -C 6 alkyl, x) --SO--C 1 -C 6 alkyl, xi) --SO 2 --C 1 -C 6 alkyl, xii) halo, xiii) --C 3 -C 7 -cycloalkyl, xiv) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are independently selected from the group consisting of: A) hydrogen, B) C 1 -C 6 alkyl, C) --OH, D) C 1 -C 6 alkoxy, E) --O--CO--C 1 -C 6 alkyl, F) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, G) --CONR 9 R 10 , H) --CO 2 H, I) --CO--O--C 1 -C 6 alkyl, J) halo, K) --NO 2 , L) --CN, and N) --CF 3 , xv) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, and xvi) --CF 3 , c) C 3 -C 12 alkenyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) C 3 -C 7 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, e) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, f) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, g) --SO 2 -phenyl, wherein phenyl is unsubstituted or substituted with with M, W and Y, wherein M, W and Y are as defined above, h) --SO 2 --C 1 -C 6 alkyl, i) or where R 5 and R 6 and the N to which they are attached may form an unsubstituted or substituted 3- to 7-membered heterocyclic ring which may include one or two additional heteroatoms independently selected from the group consisting of O, S, or NR 9 , wherein R 9 is as defined above, and where the substituent(s), attached to the carbon atom(s) in the heterocyclic ring is/are independently selected form the group consisting of: i) hydrogen, ii) --OH, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are independently, hydrogen, or C 1 -C 6 alkyl, unsubstituted or substituted with phenyl, vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --SH, x) halo, xi) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, xii) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, and xiii) --CF 3 ; 4) --N(R 5 )CO--O--R 11 , wherein R 5 is as defined above and R 11 is C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above; 5) --N(R 5 )CO--R 12 , wherein R 5 is as defined above and R 12 is a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, c) C 3 -C 12 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, e) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, or f) where R 5 and R 12 and the --NCO-- to which they are attached may form an unsubstituted or substituted 5- to 7-membered heterocyclic ring which may include one or two additional heteroatoms independently selected from the group consisting of O, S, or NR 9 , wherein R 9 is as defined above; 6) --N(R 13 )COCH(R 17 )NR 5 R 6 wherein R 5 and R 6 are as defined above, R 13 is selected from the definitions of R 5 , and R 17 is: a) hydrogen, b) C 1 -C 4 alkyl, unsubstituted or substituted with R 18 , wherein R 18 is selected from the group consisting of: i) --OH, ii) C 1 -C 6 alkoxy, iii) --O--CO--C 1 -C 6 alkyl, iv) --SH, v) --S--C 1 -C 6 alkyl, vi) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, vii) --CO 2 H, viii) --CONH 2 , ix) imidazolyl, x) indolyl, xi) phenyl, and xii) p-hydroxyphenyl, or c) phenyl; 7) --N(R 13 )CO(CH 2 ) m NR 5 R 6 , wherein m is 0 or 2-6, R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 , or where R 13 and R 5 and the --NCO(CH 2 ) m N-- to which they are attached may form an unsubstituted or substituted 5- to 7-membered heterocyclic ring; 8) --N═C(R 13 )--NR 5 R 6 , wherein R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 , and wherein if either R 5 or R 6 are hydrogen, the tautomeric structure --NHC(R 13 )═NR 5or6 is also possible; 9) --N(R 14 ) 3 + A - , wherein R 14 is C 1 -C 6 alkyl, unsubstituted or substituted with phenyl or naphthyl, and wherein A - is a counterion; 10) ##STR17## wherein R 15 and R 16 are independently, a) hydrogen, b) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, c) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, d) --CN, e) --CF 3 , f) --CO--C 1 -C 6 alkyl, or g) --CO--O--C 1 -C 6 alkyl; 11) hydroxy or C 1 -C 6 alkoxy, with the proviso that R 1 and R 2 are not simultaneously hydroxy, C 1 -C 6 alkoxy, or combinations thereof; or 12) where R 1 and R 2 may both be connected to form a 3- to 7-membered heterocyclic ring of the form: ##STR18## wherein p is zero or one, R 5 is as defined above, and Z is a) --CO--, b) --CS--, c) --CO--C 1 -alkyl, d) --CS--C 1 -alkyl, or e) C 1 -C 2 -alkyl, wherein the alkyl may be unsubstituted or substituted with one or more of the following: i) --OH, ii) C 1 -C 6 alkyl, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, vi) --CONR 9 R 10 , vii) --CO 2 H, viii) --CO--O--C 1 -C 6 alkyl, ix) --S--C 1 -C 6 alkyl, x) --SO--C 1 -C 6 alkyl, xi) --SO 2 --C 1 -C 6 alkyl, xii) halo, xiii) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, or xiv) naphthyl unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above; R 3 is hydrogen, hydroxy, or C 1 -C 6 alkoxyl; R 4 is hydrogen, or R 3 and R 4 taken together form a double bond; X is 0 or (H,OH); and n is 1 or 2.
Claim 3
Dependent Claim
20 words
A compound according to claim 1 wherein the absolute configuration of formula I is as defined in formula III: ##STR19##
Claim 4
Dependent Claim
892 words
The compound according to claim 1 wherein: R is 1) ethyl, 2) propyl, or 3) allyl; R 1 and R 2 are, independently, 1) --N 3 ; 2) --NR 5 R 6 , wherein R 5 and R 6 are independently, a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are independently selected from the group consisting of: i) hydrogen, ii) --OH, iii) C 1 -C 6 alkoxy, iv) --O--CO--C 1 -C 6 alkyl, v) --NR 9 R 10 , wherein R 9 and R 10 are independently, hydrogen, or C 1 -C 6 alkyl, unsubstituted or substituted with phenyl, vi) --CONR 9 R 10 , vii) --CO--O--C 1 -C 6 alkyl, viii) halo, xiv) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are independently selected from the group consisting of: A) hydrogen, B) C 1 -C 6 alkyl, C) --OH, D) C 1 -C 6 alkoxy, E) --O--CO--C 1 -C 6 alkyl, F) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, G) --CONR 9 R 10 , H) --CO 2 H, I) --CO--O--C 1 -C 6 alkyl, J) halo, K) --NO 2 , L) --CN, and N) --CF 3 , xv) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, and xi) --CF 3 , c) C 3 -C 12 alkenyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) C 3 -C 7 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, e) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, f) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, g) --SO 2 -phenyl, wherein phenyl is unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, h) --SO 2 --C 1 -C 6 alkyl, 3) --N(R 5 )CO--O--R 11 , wherein R 5 is as defined above and R 11 is C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above; 4) --N(R 5 )CO--R 12 , wherein R 5 is as defined above and R 12 is a) hydrogen, b) C 1 -C 12 alkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, c) C 3 -C 12 cycloalkyl, unsubstituted or substituted with R 7 and R 8 , wherein R 7 and R 8 are as defined above, d) phenyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above, or e) naphthyl, unsubstituted or substituted with M, W and Y, wherein M, W and Y are as defined above; 5) --N(R 13 )COCH(R 17 )NR 5 R 6 wherein R 5 and R 6 are as defined above, R 13 is selected from the definitions of R 5 , and R 17 is: a) hydrogen, b) C 1 -C 4 alkyl, unsubstituted or substituted with R 18 , wherein R 18 is selected from the group consisting of: i) --OH, ii) C 1 -C 6 alkoxy, iii) --O--CO--C 1 -C 6 alkyl, iv) --SH, v) --S--C 1 -C 6 alkyl, vi) --NR 9 R 10 , wherein R 9 and R 10 are as defined above, vii) --CO 2 H, viii) --CONH 2 , ix) imidazolyl, x) indolyl, xi) phenyl, and xii) p-hydroxyphenyl, or c) phenyl; 6) --N(R 13 )CO(CH 2 ) m NR 5 R 6 , wherein m is 0 or 2-6, R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 ; 7) --N═C(R 13 )--NR 5 R 6 , wherein R 5 and R 6 are as defined above, and R 13 is selected from the definitions of R 5 , and wherein if either R 5 or R 6 are hydrogen, the tautomeric structure --NHC(R 13 )═NR 5 or 6 is also possible; 8) --N(R 14 ) 3 + A - , wherein R 14 is C 1 -C 6 alkyl, unsubstituted or substituted with phenyl or naphthyl, and wherein A - is a counterion; 9) 1-(1,2,3-triazolyl), substituted with R 15 and R 16 , wherein R 15 and R 16 are a) hydrogen, b) phenyl, or c) --CO--O--C 1 -C 6 alkyl; 10) hydroxy or C 1 -C 6 alkoxy, with the proviso that R 1 and R 2 are not simultaneously hydroxy, C 1 -C 6 alkoxy, or combinations thereof; or 11) where R 1 and R 2 may both be connected to form a 3- to 7-membered heterocyclic ring of the form: ##STR20## wherein p is one, R 5 is as defined above, and Z is a) --CO--, b) --CO--C 1 -alkyl, or c) C 1 -C 2 -alkyl; R 3 is hydrogen or hydroxy; R 4 is hydrogen; X is O or (H,OH); and n is 1 or 2; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim
140 words
A compound of formula I: ##STR21## wherein: R is ethyl, propyl or allyl; R 1 and R 2 are, independently, N 3 --; H 2 N--; CH 3 NH--; (CH 3 ) 2 N--; PhCH 2 NH--; HOCH(CH 3 )CH 2 NH--; CH 2 ═CHCH 2 NH--; + (CH 3 ) 3 N--; CH 3 CONH--; CH 3 COOCH 2 CONH--; PhNHCONH--; HCONH--; CH 3 CH 2 OCONH--; CH 3 OCONH--; PhCH 2 OCONH--; HN═C(CH 3 )NH--; HN═C(CH 2 Ph)NH--; HN═CHNH--; (N'-t-butoxycarbonyl-D-phenylalanine)amido; (N'-t-butoxycarbonyl-L-phenylalanine)amido; (D-phenylalanine)amido; (L-phenylalanine)amido; cyclopropylcarboxamido; adamantylcarboxamido; 1-(4,5-dicarboethoxy-1,2,3-triazole); or hydroxy or C 1 -C 6 alkoxy, with the proviso that R 1 and R 2 are not simultaneously hydroxy, C 1 -C 6 alkoxy, or combinations thereof; R 3 is hydrogen or hydroxy; R 4 is hydrogen; X is O; and n is 2; or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim
140 words
A compound of formula I: ##STR21## wherein: R is ethyl, propyl or allyl; R 1 and R 2 are, independently, N 3 --; H 2 N--; CH 3 NH--; (CH 3 ) 2 N--; PhCH 2 NH--; HOCH(CH 3 )CH 2 NH--; CH 2 ═CHCH 2 NH--; + (CH 3 ) 3 N--; CH 3 CONH--; CH 3 COOCH 2 CONH--; PhNHCONH--; HCONH--; CH 3 CH 2 OCONH--; CH 3 OCONH--; PhCH 2 OCONH--; HN═C(CH 3 )NH--; HN═C(CH 2 Ph)NH--; HN═CHNH--; (N'-t-butoxycarbonyl-D-phenylalanine)amido; (N'-t-butoxycarbonyl-L-phenylalanine)amido; (D-phenylalanine)amido; (L-phenylalanine)amido; cyclopropylcarboxamido; adamantylcarboxamido; 1-(4,5-dicarboethoxy-1,2,3-triazole); or hydroxy or C 1 -C 6 alkoxy, with the proviso that R 1 and R 2 are not simultaneously hydroxy, C 1 -C 6 alkoxy, or combinations thereof; R 3 is hydrogen or hydroxy; R 4 is hydrogen; X is O; and n is 2; or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
341 words
A compound which is selected from: 17-ethyl-1,14-dihydroxy-12-[2'-(4"-azido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-N-(2-propenyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-methylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-methylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(1'"-adamantanecarboxamido)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-cyclopropanecarboxamido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-formamido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(4'",5'"-dicarboethoxy-1'",2'",3'"-triazole)-3"-methoxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-acetylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-hydroxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-hydroxy-3"-aminocyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-hydroxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-hydroxy-3"-aminocyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-benzylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(ethoxycarbonyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]-octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-phenylaminocarbonyl)amino-3"-methoxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]-octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-beta-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-alpha-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-beta-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-alpha-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-methylcarbamate-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylcarbamate-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-formamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1-hydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(L-phenylalanyl)-amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(L-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(D-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(D-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(aminoacetylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(aminoacetylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(2"'-hydroxypropylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(2"'-hydroxypropylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(1-aza-4-oxabicyclo[4.4.0]dec-6-yl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(1-aza-4-oxabicyclo[4.4.0]-dec-6-yl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-trimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone iodide; 17-allyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-isopropoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1-hydroxy-12-[2'-(4"-amino-3"-isopropoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-propyl-1-hydroxy-12-[2'-(4"-amino-3"-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.31.0 4 ,9 ]octacos-18-ene-2,3,20,26-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-[4"-(N'-t-butoxycarbonyl-D-phenylalanine)amido-3"-n-propyloxycyclohexyl]-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetra-methyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-[4"-(N'-t-butoxycarbonyl-L-phenylalanine)amido-3"-n-propyloxycyclohexyl]-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetra-methyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetoxyacetylamino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(1"'-adamantanecarboxamido-)3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-cyclopropanecarboxamido-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2-(4"-formamido-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"',5"'-dicarboethoxy-1"',2"',3"'-triazole)-3"-n-propyloxycyclohexyl]-1'-methyl-vinyl}-23,23-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-benzylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-trimethylamino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone-Iodide; 17-ethyl-1,2,14-trihydroxy-12-[2'-(4"-acetylamino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1.0 4 ,9 ]octacos-18-ene-3,10,16-trione; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-benzylamino-3"-methoxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-dihydroxy-12-{2'-[4"-(N'-benzylamino-3"-methoxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-phenylaminocarbonyl)amino-3"-isopropyloxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(ethoxycarbonyl)amino-3"-n-propyloxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-acetylamino-3"-n-propylcyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-dimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-n-propylyoxyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethyoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(2-phenyl-2-hydroxyethyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethyoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-morpholino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-morpholino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-n-butyloxycyclo-hexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-n-butyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-(3-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-(3-methylbutyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-(2-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-(2-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(N-(2-methyl-3-(4-hydroxyphenyl)propenyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(L-Trp)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]pctacps-18-ene-2,3,10,16-tetraone; or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim
341 words
A compound which is selected from: 17-ethyl-1,14-dihydroxy-12-[2'-(4"-azido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-N-(2-propenyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-methylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-methylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(1'"-adamantanecarboxamido)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-cyclopropanecarboxamido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-formamido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(4'",5'"-dicarboethoxy-1'",2'",3'"-triazole)-3"-methoxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-acetylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-hydroxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-hydroxy-3"-aminocyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-hydroxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-hydroxy-3"-aminocyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-benzylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(ethoxycarbonyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]-octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-phenylaminocarbonyl)amino-3"-methoxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]-octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-beta-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-alpha-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-beta-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-alpha-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-methylcarbamate-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylcarbamate-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-formamidine-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1-hydroxy-12-[2'-(4"-amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(L-phenylalanyl)-amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(L-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(D-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(D-phenylalanyl)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(aminoacetylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(aminoacetylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(2"'-hydroxypropylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(2"'-hydroxypropylamino)-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(1-aza-4-oxabicyclo[4.4.0]dec-6-yl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(1-aza-4-oxabicyclo[4.4.0]-dec-6-yl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-trimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone iodide; 17-allyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-isopropoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-allyl-1-hydroxy-12-[2'-(4"-amino-3"-isopropoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-propyl-1-hydroxy-12-[2'-(4"-amino-3"-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.31.0 4 ,9 ]octacos-18-ene-2,3,20,26-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-[4"-(N'-t-butoxycarbonyl-D-phenylalanine)amido-3"-n-propyloxycyclohexyl]-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetra-methyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-[4"-(N'-t-butoxycarbonyl-L-phenylalanine)amido-3"-n-propyloxycyclohexyl]-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetra-methyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-acetoxyacetylamino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-(1"'-adamantanecarboxamido-)3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-cyclopropanecarboxamido-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2-(4"-formamido-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"',5"'-dicarboethoxy-1"',2"',3"'-triazole)-3"-n-propyloxycyclohexyl]-1'-methyl-vinyl}-23,23-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-benzylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-trimethylamino-3"-ethoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone-Iodide; 17-ethyl-1,2,14-trihydroxy-12-[2'-(4"-acetylamino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1.0 4 ,9 ]octacos-18-ene-3,10,16-trione; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-benzylamino-3"-methoxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-dihydroxy-12-{2'-[4"-(N'-benzylamino-3"-methoxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(N'-phenylaminocarbonyl)amino-3"-isopropyloxycyclohexy]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-{2'-[4"-(ethoxycarbonyl)amino-3"-n-propyloxycyclohexyl]-1'-methylvinyl}-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-acetylamino-3"-n-propylcyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-dimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-dimethylamino-3"-n-propylyoxyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-isopropyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-benzylamino-3"-n-propyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethyoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(2-phenyl-2-hydroxyethyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethyoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-morpholino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-morpholino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-n-butyloxycyclo-hexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-n-butyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-(3-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-(3-methylbutyloxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-amino-3"-(2-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1,14-dihydroxy-12-[2'-(4"-amino-3"-(2-methylbutyloxy)cyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(N-(2-methyl-3-(4-hydroxyphenyl)propenyl)amino-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]octacos-18-ene-2,3,10,16-tetraone; 17-ethyl-1-hydroxy-12-[2'-(4"-(L-Trp)amido-3"-methoxycyclohexyl)-1'-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0 4 ,9 ]pctacps-18-ene-2,3,10,16-tetraone; or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim
77 words
The compound of claim 5 which is: ##STR22## wherein R 1 , R 2 and R 3 are selected from: ______________________________________
R.sup.1 R.sup.2 R.sup.3
______________________________________
##STR23##
##STR24##
##STR25##
##STR26##
##STR27##
##STR28##
##STR29##
##STR30## H
##STR31##
##STR32## H
##STR33##
##STR34## H
##STR35##
##STR36## H
##STR37##
##STR38## H
##STR39##
##STR40##
##STR41##
##STR42##
##STR43##
##STR44##
##STR45##
##STR46##
##STR47##
##STR48##
##STR49## H
##STR50##
##STR51##
##STR52##
##STR53##
##STR54## H
##STR55##
##STR56## H
##STR57##
##STR58## H
##STR59##
##STR60## H
##STR61##
##STR62## H.
______________________________________
Claim 10
Dependent Claim
8 words
The compound of claim 5 which is: ##STR63##
Claim 11
Dependent Claim
8 words
The compound of claim 5 which is: ##STR64##
Claim 12
Dependent Claim
8 words
The compound of claim 5 which is: ##STR65##
Claim 13
Dependent Claim
8 words
The compound of claim 5 which is: ##STR66##
Claim 14
Dependent Claim
8 words
The compound of claim 5 which is: ##STR67##
Claim 15
Dependent Claim
8 words
The compound of claim 5 which is: ##STR68##
Claim 16
Dependent Claim
8 words
The compound of claim 5 which is: ##STR69##
Claim 17
Dependent Claim
8 words
The compound of claim 5 which is: ##STR70##
Claim 18
Dependent Claim
8 words
The compound of claim 5 which is: ##STR71##
Claim 19
Dependent Claim
8 words
The compound of claim 5 which is: ##STR72##
Claim 20
Dependent Claim
8 words
The compound of claim 5 which is: ##STR73##
Claim 21
Dependent Claim
8 words
The compound of claim 5 which is: ##STR74##
Claim 22
Dependent Claim
8 words
The compound of claim 5 which is: ##STR75##
Claim 23
Dependent Claim
26 words
A pharmaceutical composition for the treatment of immunoregulatory disorders or diseases comprising a pharmaceutical carrier and a therapeutically effective amount of the compound of claim 1.
Claim 24
Dependent Claim
25 words
A pharmaceutical composition for the treatment of resistance to transplantation comprising a pharmaceutical carrier and a therapeutically effective amount of the compound of claim 1.
Claim 25
Dependent Claim
34 words
A pharmaceutical composition for the topical treatment of inflammatory and hyperproliferative skin diseases and/or cutaneous manifestations of immunologically-mediated illnesses comprising a pharmaceutical carrier and a therapeutically effective amount of the compound of claim 1.
Claim 26
Dependent Claim
26 words
A pharmaceutical composition for the treatment of reversible obstructive airways disease comprising a pharmaceutical carrier and a therapeutically effective amount of the compound of claim 1.
Claim 27
Dependent Claim
31 words
A method for the treatment of immunoregulatory disorders or diseases comprising the administration to a mammalian species in need of such treatment an effective amount of the compound of claim 1.
Claim 28
Dependent Claim
30 words
A method for the treatment of resistance to transplantation comprising the administration to a mammalian species in need of such treatment an effective amount of the compound of claim 1.
Claim 29
Dependent Claim
40 words
A method for the topical treatment of inflammatory and hyperproliferative skin diseases and or cutaneous manifestations of immunologically-mediated illnesses comprising the administration to a mammalian species in need of such treatment an effective amount of the compound of claim 1.
Claim 30
Dependent Claim
31 words
A method for the treatment of reversible obstructive airways disease comprising the administration to a mammalian species in need of such treatment of an effective amount of the compound claim 1.
References Cited (Backward Citations)
US4929611A
Cited
US4894366A
Cited
US4956352A
Cited
US4650803A
Cited
US4916138A
Cited
EP0315978A2
Cited
WO1989005304A1
Cited
EP0323042A1
Cited
EP0349061A2
Cited
US4981792A
Cited
EP0353678A2
Cited
EP0356399A2
Cited
EP0369344A1
Cited
EP0388152A2
Cited
EP0388153A2
Cited
US4987139A
Cited
WO1990014826A1
Cited
WO1991002736A1
Cited
WO1991004025A1
Cited
EP0427680A1
Cited
EP0428365A1
Cited
EP0428169A2
Cited
US5064835A
Cited
WO1991013889A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-05-03 | 1996-11-02 | 1997-05-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-05-03 | 2000-11-02 | 2001-05-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-05-03 | 2004-11-02 | 2005-05-04 | $7700.00 | Window Closed / Lapsed |